Transpharmation
Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer two distinct models to support the development of dermatological therapeutics: a naturally occurring model of canine atopic dermatitis and an induced interleukin-31 (IL-31) pruritus model. These models enable the assessment of both long-term disease-modifying therapies and rapid-acting antipruritic agents. Committed to on-time data delivery and providing flexible, customized solutions, we support clients in optimizing preclinical assets for the development of life-changing medicines.
